Search Results - Drug Therapy

Refine Results
  1. 1

    Pharmacogenomics in cancer therapy

    Published 2015
    Table of Contents: “…Contents: Pharmacogenomics in cancer therapy -- Types and sources of genetic variation -- Adverse drug reactions -- Techniques to measure genetic variation -- Cancer pharmacogenomics and drug selection -- Cancer pharmacogenomics and drug toxicity -- Irinotecan (CPT-11) pathway -- Cancer pharmacogenomics and drug outcomes -- Tamoxifen pathway -- Uses of pharmacogenomics.…”
    Get full text
    Series
    Electronic Video
  2. 2

    Pharmacogenomics in cancer therapy

    Published 2015
    Table of Contents: “…Contents: Pharmacogenomics in cancer therapy -- Types and sources of genetic variation -- Adverse drug reactions -- Techniques to measure genetic variation -- Cancer pharmacogenomics and drug selection -- Cancer pharmacogenomics and drug toxicity -- Irinotecan (CPT-11) pathway -- Cancer pharmacogenomics and drug outcomes -- Tamoxifen pathway -- Uses of pharmacogenomics.…”
    Get full text
    Series
    Electronic Video
  3. 3

    Pharmacogenomics in cancer therapy

    Published 2015
    Table of Contents: “…Contents: Pharmacogenomics in cancer therapy -- Types and sources of genetic variation -- Adverse drug reactions -- Techniques to measure genetic variation -- Cancer pharmacogenomics and drug selection -- Cancer pharmacogenomics and drug toxicity -- Irinotecan (CPT-11) pathway -- Cancer pharmacogenomics and drug outcomes -- Tamoxifen pathway -- Uses of pharmacogenomics.…”
    Get full text
    Series
    Electronic Video
  4. 4

    Germline pharmacogenomics as a tool to individualize therapy in breast cancer

    Published 2009
    Subjects: “…Breast Neoplasms drug therapy.…”
    Get full text
    Series
    Electronic Video
  5. 5

    Genetic determinants of metabolism clinical applications in psychiatry /

    Published 2007
    Subjects: “…Mental Disorders drug therapy.…”
    Get full text
    Series
    Electronic Video
  6. 6

    Role of molecular markers in guiding therapy in cancer

    Published 2015
    Subjects:
    Get full text
    Series
    Electronic Video
  7. 7

    Pharmacogenetics progress, pitfalls and clinical potential /

    Published 2008
    Subjects: “…Cardiovascular Diseases drug therapy.…”
    Get full text
    Series
    Electronic Video
  8. 8
  9. 9

    CML genetic paradigm of targeted therapy, part 1 of 2 /

    Published 2015
    Subjects: “…Leukemia, Myelogenous, Chronic, BCR-ABL Positive drug therapy.…”
    Get full text
    Series
    Electronic Video
  10. 10

    Gene profiling in breast cancer

    Published 2009
    Subjects:
    Get full text
    Series
    Electronic Video
  11. 11

    CML genetic paradigm of targeted therapy, part 2 of 2 /

    Published 2015
    Subjects: “…Leukemia, Myelogenous, Chronic, BCR-ABL Positive drug therapy.…”
    Get full text
    Series
    Electronic Video
  12. 12

    Germline pharmacogenomics as a tool to individualize therapy in breast cancer

    Published 2009
    Subjects: “…Breast Neoplasms drug therapy. 113143…”
    Get full text
    Series
    Electronic Video
  13. 13

    Germline pharmacogenomics as a tool to individualize therapy in breast cancer

    Published 2009
    Subjects: “…Breast Neoplasms drug therapy. 113143…”
    Get full text
    Series
    Electronic Video
  14. 14

    CML genetic paradigm of targeted therapy, part 1 of 2 /

    Published 2015
    Subjects: “…Leukemia, Myelogenous, Chronic, BCR-ABL Positive drug therapy. 100747…”
    Get full text
    Series
    Electronic Video
  15. 15

    CML genetic paradigm of targeted therapy, part 1 of 2 /

    Published 2015
    Subjects: “…Leukemia, Myelogenous, Chronic, BCR-ABL Positive drug therapy. 100747…”
    Get full text
    Series
    Electronic Video
  16. 16

    Role of molecular markers in guiding therapy in cancer

    Published 2015
    Subjects:
    Get full text
    Series
    Electronic Video
  17. 17

    Role of molecular markers in guiding therapy in cancer

    Published 2015
    Subjects:
    Get full text
    Series
    Electronic Video
  18. 18

    UGT1A1 polymorphisms and irinotecan toxicity in colorectal cancer patients

    Published 2009
    Subjects:
    Get full text
    Series
    Electronic Video
  19. 19

    CML genetic paradigm of targeted therapy, part 2 of 2 /

    Published 2015
    Subjects: “…Leukemia, Myelogenous, Chronic, BCR-ABL Positive drug therapy. 100842…”
    Get full text
    Series
    Electronic Video
  20. 20

    CML genetic paradigm of targeted therapy, part 2 of 2 /

    Published 2015
    Subjects: “…Leukemia, Myelogenous, Chronic, BCR-ABL Positive drug therapy. 100842…”
    Get full text
    Series
    Electronic Video